363 related articles for article (PubMed ID: 18789503)
21. Neuroprotective strategies for the neonatal brain.
Degos V; Loron G; Mantz J; Gressens P
Anesth Analg; 2008 Jun; 106(6):1670-80. PubMed ID: 18499596
[TBL] [Abstract][Full Text] [Related]
22. Targeting mitochondrial ATP-sensitive potassium channels--a novel approach to neuroprotection.
Busija DW; Lacza Z; Rajapakse N; Shimizu K; Kis B; Bari F; Domoki F; Horiguchi T
Brain Res Brain Res Rev; 2004 Nov; 46(3):282-94. PubMed ID: 15571770
[TBL] [Abstract][Full Text] [Related]
23. Disease-modifying drugs and Parkinson's disease.
Allain H; Bentué-Ferrer D; Akwa Y
Prog Neurobiol; 2008 Jan; 84(1):25-39. PubMed ID: 18037225
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin as a novel neuroprotectant.
Genc S; Koroglu TF; Genc K
Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
[TBL] [Abstract][Full Text] [Related]
25. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310
[TBL] [Abstract][Full Text] [Related]
26. A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent.
Savino R; Ciliberto G
Cell Death Differ; 2004 Jul; 11 Suppl 1():S2-4. PubMed ID: 15243576
[No Abstract] [Full Text] [Related]
27. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
Jelkmann W; Wagner K
Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats.
Cherian L; Goodman JC; Robertson C
J Pharmacol Exp Ther; 2007 Aug; 322(2):789-94. PubMed ID: 17470644
[TBL] [Abstract][Full Text] [Related]
29. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
Kumar A; Loane DJ
Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
[TBL] [Abstract][Full Text] [Related]
30. Progesterone in the clinical treatment of acute traumatic brain injury.
Stein DG; Wright DW
Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
[TBL] [Abstract][Full Text] [Related]
31. I can't get no satisfaction: still no neuroprotection for Parkinson disease.
Ahlskog JE
Neurology; 2007 Oct; 69(15):1476-7. PubMed ID: 17923609
[No Abstract] [Full Text] [Related]
32. Cell death in the injured brain: roles of metallothioneins.
Pedersen MØ; Larsen A; Stoltenberg M; Penkowa M
Prog Histochem Cytochem; 2009; 44(1):1-27. PubMed ID: 19348909
[TBL] [Abstract][Full Text] [Related]
33. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
Chen JF; Sonsalla PK; Pedata F; Melani A; Domenici MR; Popoli P; Geiger J; Lopes LV; de Mendonça A
Prog Neurobiol; 2007 Dec; 83(5):310-31. PubMed ID: 18023959
[TBL] [Abstract][Full Text] [Related]
34. Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis.
Ahn KH; Kim YS; Kim SY; Huh Y; Park C; Jeong JW
Neurosci Lett; 2009 Jan; 449(2):93-7. PubMed ID: 19000740
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of erythropoietin in treating experimental traumatic brain injury: a systematic review of controlled trials in animal models.
Peng W; Xing Z; Yang J; Wang Y; Wang W; Huang W
J Neurosurg; 2014 Sep; 121(3):653-64. PubMed ID: 25036201
[TBL] [Abstract][Full Text] [Related]
36. Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions.
Feeser VR; Loria RM
J Neuroimmunol; 2011 Aug; 237(1-2):4-12. PubMed ID: 21777982
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotection in spinal cord injury.
Wyndaele JJ
Spinal Cord; 2009 Oct; 47(10):715. PubMed ID: 19794416
[No Abstract] [Full Text] [Related]
38. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury.
Sayeed I; Stein DG
Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?
Grasso G; Sfacteria A; Cerami A; Brines M
Neuroscientist; 2004 Apr; 10(2):93-8. PubMed ID: 15070483
[TBL] [Abstract][Full Text] [Related]
40. Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury.
Shein NA; Grigoriadis N; Alexandrovich AG; Simeonidou C; Spandou E; Tsenter J; Yatsiv I; Horowitz M; Shohami E
J Neurotrauma; 2008 Feb; 25(2):112-23. PubMed ID: 18260794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
